Boston Scientific Acquires Axonics, Inc.

Axonius Acquires Cynerio

July 30, 2025

Cybersecurity

Axonius has acquired Cynerio, a specialist in medical-device and healthcare IoT security, to accelerate the company's expansion into the healthcare market. Deal terms were reported at about $180 million (potentially rising to $250 million on milestones), while Axonius' announcement described the transaction as "more than $100 million" in a cash-and-stock deal.

Boston Scientific Acquires Valencia Technologies

January 12, 2026

Medical Devices

On January 12, 2026, Boston Scientific acquired Valencia Technologies, the developer of the eCoin System — a coin-sized subcutaneous neuromodulation device for hypertension. The acquisition expands Boston Scientific's neuromodulation and cardiovascular device portfolio by adding a novel, minimally invasive therapy and provides Valencia access to Boston Scientific's regulatory, distribution, and commercialization resources.

Boston Scientific Acquires Baylis Medical Company Inc.

October 6, 2021

Medical Devices

Boston Scientific Corporation agreed to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition expands Boston Scientific’s electrophysiology and structural heart portfolios by adding Baylis’s RF NRG and VersaCross transseptal platforms and complementary guidewires, sheaths and dilators; Baylis was expected to generate nearly $200 million in net sales in 2022.

Boston Scientific Acquires Relievant Medsystems, Inc.

September 19, 2023

Medical Devices

Boston Scientific Corporation agreed to acquire Relievant Medsystems, Inc. to expand its neuromodulation portfolio and add the Intracept intraosseous nerve ablation system for vertebrogenic chronic low back pain. The deal includes an $850 million upfront cash payment plus contingent payments tied to sales, and is expected to close in the first half of 2024; Relievant was projected to generate more than $70 million in sales in 2023.

Axonics Acquires Contura Ltd (Bulkamid)

February 25, 2021

Medical Devices

Axonics Modulation Technologies, Inc. acquired London-based Contura Ltd. and its Bulkamid urethral bulking agent for $200 million in cash and stock plus a potential $35 million milestone. The acquisition expands Axonics' portfolio into stress urinary incontinence (SUI), leverages its commercial footprint in the U.S. and Europe, and is expected to be immediately accretive to Axonics' financial results.

ClinicalMind Acquires IC Axon

October 2, 2020

Healthcare Services

ClinicalMind, a healthcare communications firm, has acquired IC Axon, a Montreal-based developer of science-driven clinical and sales training for pharmaceutical, biotech and medical device companies. The deal adds IC Axon's digital learning and in-house clinical expertise (a team of over 90 employees) to ClinicalMind's strategic and tactical offerings to better support clients preparing for product launches and field-team training.